PMID- 27579722
OWN - NLM
STAT- MEDLINE
DCOM- 20181009
LR  - 20181009
IS  - 0025-0244 (Print)
IS  - 0025-0244 (Linking)
VI  - 60
IP  - 3
DP  - 2016 Sep
TI  - [3rd Hungarian Breast Cancer Consensus Conference - Radiotherapy Guidelines].
PG  - 229-39
AB  - The radiotherapy expert panel revised and updated the radiotherapy (RT) 
      guidelines accepted in 2009 at the 2nd Hungarian Breast Cancer Consensus 
      Conference based on new scientific evidence. Radiotherapy of the conserved breast 
      is indicated in ductal carcinoma in situ (St. 0), as RT decreases the risk of 
      local recurrence by 60%. In early stage (St. I-II) invasive breast cancer RT 
      remains a standard treatment following breast conserving surgery. However, in 
      elderly (>/=70 years) patients with stage I, hormone receptor positive tumour 
      hormonal therapy without RT can be considered. Hypofractionated (15x2.67 Gy) 
      whole breast irradiation and for selected cases accelerated partial breast 
      irradiation are validated treatment alternatives of conventional (25x2 Gy) whole 
      breast irradiation. Following mastectomy RT significantly decreases the risk of 
      locoregional recurrence and improves overall survival of patients having 1 to 3 
      (pN1a) or >/=4 (pN2a, pN3a) positive axillary lymph nodes. In selected cases of 
      patients with 1 to 2 positive sentinel lymph nodes axillary dissection can be 
      omitted and substituted with axillary RT. After neoadjuvant chemotherapy (NAC) 
      followed by breast conserving surgery whole breast irradiation is mandatory, 
      while after NAC followed by mastectomy locoregional RT should be given in cases 
      of initial stage III-IV and ypN1 axillary status.
FAU - Polgar, Csaba
AU  - Polgar C
AD  - Sugarterapias Kozpont, Orszagos Onkologiai Intezet, Budapest, Hungary. 
      polgar@oncol.hu.
FAU - Kahan, Zsuzsanna
AU  - Kahan Z
AD  - Onkoterapias Klinika, Szegedi Tudomanyegyetem, Szeged, Hungary.
FAU - Csejtei, Andras
AU  - Csejtei A
AD  - Onkoradiologiai Osztaly, Markusovszky Egyetemi Oktatokorhaz, Szombathely, 
      Hungary.
FAU - Gabor, Gabriella
AU  - Gabor G
AD  - Onkoradiologiai Kozpont, Bacs-Kiskun Megyei Korhaz, Kecskemet, Hungary.
FAU - Landherr, Laszlo
AU  - Landherr L
AD  - Fovarosi Onkoradiologiai Kozpont, Uzsoki utcai Korhaz, Budapest, Hungary.
FAU - Mangel, Laszlo
AU  - Mangel L
AD  - Onkoterapias Intezet, Pecsi Tudomanyegyetem, Pecs, Hungary.
FAU - Mayer, Arpad
AU  - Mayer A
AD  - Fovarosi Onkoradiologiai Kozpont, Uzsoki utcai Korhaz, Budapest, Hungary.
FAU - Fodor, Janos
AU  - Fodor J
AD  - Sugarterapias Kozpont, Orszagos Onkologiai Intezet, Budapest, Hungary. 
      polgar@oncol.hu.
LA  - hun
PT  - Consensus Development Conference
PT  - Journal Article
TT  - III. Emlorak Konszenzus Konferencia - Sugarterapias iranyelvek.
DEP - 20160615
PL  - Hungary
TA  - Magy Onkol
JT  - Magyar onkologia
JID - 9313833
SB  - IM
MH  - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MH  - Breast Neoplasms/*therapy
MH  - Chemotherapy, Adjuvant
MH  - Female
MH  - Humans
MH  - Mastectomy
MH  - *Mastectomy, Segmental
MH  - *Neoadjuvant Therapy
MH  - Neoplasm Staging
MH  - Radiotherapy, Adjuvant
EDAT- 2016/09/01 06:00
MHDA- 2018/10/10 06:00
CRDT- 2016/09/01 06:00
PHST- 2016/06/09 00:00 [received]
PHST- 2016/06/15 00:00 [accepted]
PHST- 2016/09/01 06:00 [entrez]
PHST- 2016/09/01 06:00 [pubmed]
PHST- 2018/10/10 06:00 [medline]
AID - MagyOnkol.2016.60.3.229 [pii]
PST - ppublish
SO  - Magy Onkol. 2016 Sep;60(3):229-39. Epub 2016 Jun 15.